SAVIENT PHARMACEUTICALS INC

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

organization

SEC Insider

$64.6M

801 transactions

Summary

SAVIENT PHARMACEUTICALS INC is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: $471KSales: $13.5M31 insiders

Date	Insider	Type	Value
2013-10-15	CROWLEY Richard(Co-President and COO)	Sell	$8K
2013-10-15	Bahrt Kenneth(SVP, Chief Medical Officer)	Sell	$5K
2013-12-04	THOMPSON VIRGIL	Sell	$2K
2013-10-17	JAEGER STEPHEN O	Sell	$2K
2013-10-15	Hamill John(Co-President and CFO)	Sell	$2K
2013-10-15	Gionco David(Chief Accounting Officer)	Sell	$2K
2013-10-15	CROWLEY Richard(Co-President and COO)	Sell	$893.2
2013-10-15	Gionco David(Chief Accounting Officer)	Sell	$800
2013-10-15	Gionco David(Chief Accounting Officer)	Sell	$680
2013-10-16	Constantine Ginger	Sell	$616.35
2013-10-15	Gionco David(Chief Accounting Officer)	Sell	$438.08
2013-10-15	Hamill John(Co-President and CFO)	Sell	$400
2013-10-15	Bahrt Kenneth(SVP, Chief Medical Officer)	Sell	$312.88
2013-10-16	Bahrt Kenneth(SVP, Chief Medical Officer)	Sell	$245
2013-10-15	Gionco David(Chief Accounting Officer)	Sell	$240
2013-10-16	Bahrt Kenneth(SVP, Chief Medical Officer)	Sell	$168
2013-10-15	Hamill John(Co-President and CFO)	Sell	$120
2013-10-16	Bahrt Kenneth(SVP, Chief Medical Officer)	Sell	$112
2013-10-15	Bahrt Kenneth(SVP, Chief Medical Officer)	Sell	$52.88
2013-10-16	Bahrt Kenneth(SVP, Chief Medical Officer)	Sell	$35

SEC filings: SEC EDGAR

Activity data: SEC EDGAR

SAVIENT PHARMACEUTICALS INC — Contributions, Lobbying & Contracts | Poliscope